Ubiquitin-Conjugating Enzyme E2I (UBE2I) Peptide
UBE2I
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits UBE2I
- UBE2I (Ubiquitin-Conjugating Enzyme E2I (UBE2I))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-UBE2I antibody (Catalog #: ARP43022_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- UBE2I (Ubiquitin-Conjugating Enzyme E2I (UBE2I))
- Synonymes
- C358B7.1 Peptide, P18 Peptide, UBC9 Peptide, ubc9 Peptide, ube2ia Peptide, zUbc9 Peptide, 5830467E05Rik Peptide, F830028O17Rik Peptide, Ubce2i Peptide, Ubce9 Peptide, UbcE2A Peptide, ubce9 Peptide, T13J8.70 Peptide, T13J8_70 Peptide, UBIQUITIN-PROTEIN LIGASE Peptide, ubiquitin conjugating enzyme 9 Peptide, ubiquitin conjugating enzyme E2 I Peptide, ubiquitin-conjugating enzyme E2Ib Peptide, ubiquitin-conjugating enzyme E2L Peptide, ubiquitin-conjugating enzyme E2I Peptide, ubiquitin conjugating enzyme E2I S homeolog Peptide, ubiquitin conjugating enzyme 9 Peptide, SUMO-conjugating enzyme UBC9 Peptide, UBE2I Peptide, ube2ib Peptide, UBE2L Peptide, Ube2i Peptide, ube2i.S Peptide, UBC9 Peptide, ubc-9 Peptide, LOC108703134 Peptide
- Sujet
-
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. UBE2I is a member of the E2 ubiquitin-conjugating enzyme family.
Alias Symbols: C358B7.1, P18, UBC9
Protein Interaction Partner: CBX4,CEBPE,CHD3,DAXX,DNMT3B,E1,HIPK2,HTNVsSgp1,KCNK1,PIAS1,PIAS2,RANBP2,SALL1,SIAH1,SIAH1,SIAH2,SIAH2,SUMO1,SUMO1,TDP2,TP53,TP53,TRAF4,APEX1,AR,ARNT,ATF2,ATXN1,BLMH,C18orf25,CBX4,CEBPE,CHD3,CHMP1A,CHMP4B,DACH1,DAXX,DNMT3A,DNMT3B,ELK1,EP300,ESR1,ETS1,ETV6,FAS,FHIT,FMR1,GMEB1,GMEB2,HABP4,HDAC1,HGS,HIPK2,HIST2H4A,HNF4A,HNRNPD,HNRNPK,HSF2,IKZF1,IKZF3,IPO13,JUN,KCNK1,LMNA,MAPK1IP1L,MITF,MKL1,MYB,NIN,NR1D2,NR1H2,NR3C1,NUDCD3,PDLIM7,PHC1,PIAS1,PIAS2,PPM1J,PRPF40A,PTEN,RAD51,RAD52,RAD54B,RANBP2,RANGAP1,RIPK2,RORB,SALL1,SATB1,SCNN1A,SKIL,SLC2A1,SLC2A4,SMAD4,SNIP1,SOX10,SOX4,SP100,SP3,SREBF1,SREBF2,STAT1,STRA13,SUMO1,SUMO2,SUMO3,TCF3,TDP2,TFAP2B,TFAP2C,TNFRSF1A,TOP1,TOPORS,TP53,TRAF4,TRIM29,TRIM63,UBA2,UBE2I,UCHL1,UNC119,WT1,ZBED1,ZNF451,ZNF646,AR,ATF2,BLMH,C18orf25,CHD3,CHMP4B,CHUK,DACH1,DAXX,DNMT3A,DNMT3B,ESR1,ETS1,FAS,FHIT,FMR1,GCM1,HDAC4,HGS,HIPK2,HNRNPC,HNRNPK,HSF2,IKZF1,IKZF3,IPO13,JUN,MAP3K1,MAPK1IP1L,MITF,NUDCD3,PDLIM7,PDZK1,PHC1,PIAS1,PIAS2,PML,PPM1J,PTEN,RAD51,RAD52,RAD54B,RANBP2,RANBP2,RANGAP1,RANGAP1,RB1,RIPK2,Rangap1,SAE1,SALL1,SATB1,SCNN1A,SIAH1,SIAH2,SMAD4,SP100,SREBF1,SREBF2,SUMO1,SUMO3,SUZ12,Scnn1g,TCF3,TDG,TDP2,TNFRSF1A,TOP1,TOPORS,TP53,TP73,TRIM29,TRIM54,TRIM55,TRIM63,UBA2,UBE2I,UBE2K,UCHL1,UNC119,WT1,ZBED1,ZNF451,ZNF646
Protein Size: 474 - Poids moléculaire
- 52 kDa
- ID gène
- 7329
- NCBI Accession
- NM_018045, NP_003336
- UniProt
- P63279
-
Vous êtes ici:
